DAIC

DECEMBER 14, 2023

Henry Ford Health's National Cardiogenic Shock Initiative research team. Cardiogenic shock is a critical condition in which the heart is unable to pump enough blood to sustain the body’s needs, depriving vital organs of blood supply. This can cause those organs to eventually stop functioning. In the U.S.,

Cardiogenic Shock 105

Cardiogenic Shock Heart attacks Heart Attack Myocardial Infarction 105

Cardiology Update

JUNE 4, 2024

The post DanGer Shock: Microaxial Flow Pump versus Standard Care in Infarct-Related Cardiogenic Shock appeared first on Cardiology Update. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram.

Cardiogenic Shock 108

Cardiogenic Shock Myocardial Infarction Research Circulation 108

American College of Cardiology

APRIL 7, 2024

The goal of the DanGer Shock trial was to compare the safety and efficacy of Impella CP on top of standard care compared with standard care alone among patients with ST-segment elevation myocardial infarction (STEMI) and cardiogenic shock.

Cardiogenic Shock 74

Cardiogenic Shock Myocardial Infarction STEMI Article 74

Open Heart

FEBRUARY 17, 2025

Background Despite limited beneficial evidence, mechanical circulatory support (MCS) is commonly used in patients with acute myocardial infarction-related cardiogenic shock (AMI-CS). In this Dutch registry, we investigated MCS usage, associated patient characteristics and clinical outcomes.

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Aortic Outcomes 52

American College of Cardiology

MARCH 18, 2025

A simplified risk stratification model based on the cardiogenic shock (CS) classification system from the Society for Cardiovascular Angiography and Intervention (SCAI) effectively predicts in-hospital mortality in postcardiotomy (PC) patients, according to a retrospective, observational study.

Cardiogenic Shock 72

Cardiogenic Shock Hospital Article 72

Medical Xpress - Cardiology

DECEMBER 13, 2023

Published results of a large, national heart attack study show that patients with a life-threatening complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at Henry Ford Health, in collaboration with 80 hospitals nationwide.

Cardiogenic Shock 94

Cardiogenic Shock Heart attacks Heart Attack Hospital 94

American College of Cardiology

MARCH 17, 2025

The ACC has released its first Concise Clinical Guidance focused on best practices for the evaluation and management of patients with cardiogenic shock (CS).

Cardiogenic Shock 67

Cardiogenic Shock Best Practices Article 67

European Journal of Heart Failure

FEBRUARY 23, 2024

Cardiogenic shock is a primary cardiac disorder that results in both clinical and biochemical evidence of tissue hypoperfusion and can lead to multi-organ failure and death depending on its severity. Despite some advances in cardiogenic shock management, this clinical syndrome is still burdened by an extremely high mortality.

Cardiogenic Shock 75

Cardiogenic Shock Myocardial Infarction Article 75

CardiacWire

SEPTEMBER 25, 2024

Windtree Therapeutics’ istaroxime appears to have scored in its latest Phase 2b trial , showing that the steroidal drug significantly improves systolic blood pressure in cardiogenic shock patients. That could be a big deal in the cardiogenic shock space, which many believe is still in need of more effective treatments.

Cardiogenic Shock 59

Cardiogenic Shock Blood Pressure Heart Failure Cardiac Function 59

American College of Cardiology

FEBRUARY 1, 2024

What are the characteristics and outcomes of cardiogenic shock (CS) in children hospitalized for acute decompensated heart failure (ADHF)?

Cardiogenic Shock 66

Cardiogenic Shock Outcomes Heart Failure Hospital 66

Circulation

FEBRUARY 26, 2024

Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. Age is a nonmodifiable risk factor for mortality in patients with cardiogenic shock and is often considered in the decision-making process for eligibility for various therapies.

Cardiogenic Shock 74

Cardiogenic Shock Best Practices Heart Transplant Transplant 74

All About Cardiovascular System and Disorders

APRIL 9, 2024

When the heart is not able to pump enough blood for the needs of the body and the blood pressure falls, it is known as cardiogenic shock. Most important cause of cardiogenic shock is a heart attack. Cardiogenic shock is a potentially life threatening condition and needs urgent treatment.

Cardiogenic Shock 52

Cardiogenic Shock Blood Pressure Heart attacks Heart Attack 52

Dr. Smith's ECG Blog

MAY 26, 2023

A 20-something presented after a huge verapamil overdose in cardiogenic shock. Today's patient is a young male who presented in cardiogenic shock following a massive verapamil overdose. He had been seen at an outside institution and been given 6 g calcium gluconate, KCl, and a norepinephrine drip. The initial K was 3.0

Cardiogenic Shock 98

Cardiogenic Shock Arrhythmia Blog Education 98

Circulation

JANUARY 20, 2025

Advances in critical care therapies for patients with cardiogenic shock (CS), including temporary mechanical circulatory support and multidisciplinary shock teams, have led to improved survival to hospital discharge, ranging from 60% to 70%. Circulation, Volume 151, Issue 3 , Page 257-271, January 21, 2025.

Cardiogenic Shock 58

Cardiogenic Shock Quality of Life Critical Care Hospital 58

Frontiers in Cardiovascular Medicine

JANUARY 28, 2025

Long COVID-19 was associated with a higher risk of thromboembolic disorders [HR 3.12 (1.60, 6.08)], coronary heart disease [HR 1.61 (1.13, 2.31)], stroke [HR 1.71 (1.07,2.72)], arrhythmia [HR 1.60 (1.13, 2.26)], cardiomyopathy [HR 1.71 (1.12, 2.61)], myocarditis [HR 6.11 (4.17,8.94)], hypertension [HR 1.70 (1.56, 1.85)], heart failure [HR 1.72 (1.15,2.59)] (..)

COVID-19 95

COVID-19 Cardiogenic Shock Cardiomyopathy Outcomes 95

American College of Cardiology

APRIL 7, 2024

Implantation of the Impella CP micro-axial flow pump may increase survival at six months among patients with STEMI complicated by cardiogenic shock (CS), according to the results of the DanGer Shock study.

Cardiogenic Shock 60

Cardiogenic Shock STEMI Article 60

ECG Cases

JANUARY 4, 2022

What is the preferred order of vasopressors and ionotropes in the management of cardiogenic shock? How can we best pick up occult cardiogenic shock before it floured shock kicks in? The post Ep 164 Cardiogenic Shock Simplified appeared first on Emergency Medicine Cases.

Cardiogenic Shock 52

Cardiogenic Shock Heart Failure Aortic Stenosis 52

The New England Journal of Medicine

MARCH 13, 2024

An evaluation showed 2-mm ST-segment elevations in the inferior leads on electrocardiography, cardiogenic shock, and a new systolic murmur. A 55-year-old man had an out-of-hospital cardiac arrest. A diagnosis was made.

Cardiogenic Shock 66

Cardiogenic Shock Cardiac Arrest Hospital 66

American College of Cardiology

JUNE 25, 2024

Cardiogenic shock is a common complication in patients who present with acute myocardial infarction (AMI) and is the leading cause of death in this population. Even with immediate revascularization, death rates remain high.

Cardiogenic Shock 58

Cardiogenic Shock Myocardial Infarction Article 58

European Journal of Heart Failure

JANUARY 17, 2025

Predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in patients with cardiogenic shock. RRT, renal replacement therapy. interquartile range 4.112.7] mmol/L).

Cardiogenic Shock 66

Cardiogenic Shock Cardiac Arrest Myocardial Infarction Hospital 66

Nature Reviews - Cardiology

APRIL 22, 2024

Nature Reviews Cardiology, Published online: 23 April 2024; doi:10.1038/s41569-024-01035-9 Data from the DanGer Shock trial demonstrate that implantation of a microaxial flow pump in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock increases the survival rate compared with standard care alone.

Cardiogenic Shock 52

Cardiogenic Shock STEMI Myocardial Infarction 52

Becker's Hospital Review - Cardiology

DECEMBER 4, 2024

Baylor Scott & White The Heart Hospital-Plano in Texas cut times of cardiogenic shock diagnosis in half after implementing a quality improvement project that included nurse education and an electronic shock team alert, according to a study published Dec. 1 in Critical Care Nurse.

Cardiogenic Shock 52

Cardiogenic Shock Nursing Education Critical Care 52

HCPLive

JANUARY 14, 2025

AHN's specialized Shock Team at Allegheny General Hospital works to fight against cardiogenic shock.

Cardiogenic Shock 52

Cardiogenic Shock Hospital 52

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundVenoarterial extracorporeal membrane oxygenation (VA‐ECMO) is increasingly used for patients with cardiogenic shock. ConclusionsIn patients with cardiogenic shock on VA‐ECMO, LVU with Impella, particularly with 2.5/CP, Journal of the American Heart Association, Ahead of Print. and 16.4%, respectively.

Cardiogenic Shock 65

Cardiogenic Shock Aortic Hospital Outcomes 65

American College of Cardiology

SEPTEMBER 13, 2024

The goal of the ECLS-SHOCK trial was to evaluate extracorporeal life support (ECLS) compared with control among patients with acute myocardial infarction (MI) and cardiogenic shock.

Cardiogenic Shock 49

Cardiogenic Shock Myocardial Infarction Article 49

American College of Cardiology

SEPTEMBER 11, 2024

In this week’s View, Dr. Eagle looks at temporary mechanical circulatory support in infarct-related cardiogenic shock.

Cardiogenic Shock 53

Cardiogenic Shock AFIB Article 53

Dr. S. Venkatesan MD

DECEMBER 29, 2023

Cardiogenic shock (CS)is the most feared event following STEMI. Non-STEMI vs. STEMI Cardiogenic Shock: Clinical Profile and Long-Term Outcomes. The incidence is up to 5 to 10% with a mortality rate of around 50-60%. Still, we are finding it hard to bring this down below 50 %. Reference 1.Martínez J Clin Med.

Cardiogenic Shock 52

Cardiogenic Shock STEMI Myocardial Infarction Document 52

DAIC

DECEMBER 18, 2024

with SmartAssist and Impella CP with SmartAssist heart pumps, granting premarket approval (PMA) for use in specific pediatric patients with symptomatic acute decompensated heart failure (ADHF) and cardiogenic shock. and Impella CP, both left-sided heart pumps, for pediatric patients with symptomatic ADHF and cardiogenic shock.

Pediatrics 52

Pediatrics Cardiogenic Shock Heart Failure Quality of Life 52

Journal of Cardiothoracic Surgery

FEBRUARY 19, 2025

Patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) face high mortality rates. Extracorporeal Membrane Oxygenation (ECMO) therapy offers critical support in these cases, yet i.

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Risk Factors Research 52

Journal of Cardiothoracic Surgery

FEBRUARY 2, 2024

Temporary mechanical circulatory support is a treatment of choice for patients in severe cardiogenic shock. Combining veno-arterial extracorporeal life support (ECLS) with devices that enable left ventricular.

Cardiogenic Shock 52

Cardiogenic Shock 52

American College of Cardiology

MARCH 12, 2024

The following are key points to remember from an American Heart Association Scientific Statement on cardiogenic shock (CS) in older adults, which focuses on age-associated risks and approach to management.

Cardiogenic Shock 45

Cardiogenic Shock Article 45

The New England Journal of Medicine

APRIL 6, 2024

Acute myocardial infarction–related cardiogenic shock (AMI-CS) is characterized by systemic hypoperfusion due to cardiomyocyte necrosis and ventricular dysfunction.1 2 Prompt reperfusion.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Hospital 40

Frontiers in Cardiovascular Medicine

JANUARY 3, 2024

Patients at each shock stage may behave and present differently with a spectrum of shock severity and adverse outcomes. Shock severity, shock aetiology, and several factors should be integrated in management decision-making.

Cardiogenic Shock 90

Cardiogenic Shock Myocardial Infarction Heart Failure Outcomes 90

The American Journal of Cardiology

JANUARY 25, 2025

Publication date: Available online 24 January 2025 Source: The American Journal of Cardiology Author(s): Eric J. Hall, Colby R. Ayers, Nicholas S. Hendren, Christopher Clark, Amit Saha, Hadi Beaini, Isabella L. Alexander, Evan P. Gee, Ian R. McConnell, Emily S. Samson, Roslyn J. Saplicki, Christopher S. Grubb, Grant Tucker, Justin L.

Cardiogenic Shock 40

Cardiogenic Shock Hospital Outcomes 40

The American Journal of Cardiology

NOVEMBER 14, 2024

Publication date: Available online 14 November 2024 Source: The American Journal of Cardiology Author(s): Pedro Arturo Villablanca, Raef Ali Fadel, Gennaro Giustino, Ahmad Jabri, Mir Babar Basir, Jennifer Cowger, Khaldoon Alaswad, Brian O'Neill, Pedro Engel Gonzalez, Gillian Grafton Gyzm, Tiberio Frisoli, James Lee, Lindsey Aurora, Sarah Gorgis, Hassan (..)

Cardiogenic Shock 40

Cardiogenic Shock Outcomes 40

Circulation: Heart Failure

JULY 9, 2024

Circulation: Heart Failure, Ahead of Print.

Cardiogenic Shock 75

Cardiogenic Shock Heart Failure Circulation 75

Medical Xpress - Cardiology

DECEMBER 2, 2024

A cardiovascular specialty hospital in north Texas decreased time to diagnosis for patients with cardiogenic shock by more than half, according to a study published in Critical Care Nurse.

Cardiogenic Shock 40

Cardiogenic Shock Critical Care Nursing Hospital 40